Granted Patent
B2
US 8,614,340 · App. 13/384,383 · Granted Dec 24, 2013
Bicyclic compound and use thereof for medical purposes
Inventors:
Tohru Kambe (Osaka, JP); Toru Maruyama (Osaka, JP); Shinsaku Yamane (Osaka, JP); Satoshi Nakayama (Osaka, JP); Kousuke Tani (Osaka, JP)
Assignee:
Ono Pharmaceuticals Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Since a compound represented by the general formula (I) (wherein definition of each group is as described in the specification), a salt thereof, a solvate thereof, or a prodrug thereof has strong and sustaining intraocular pressure lowering activity and, further, has no side effect on eyes such as ocular stimulating property (hyperemia, corneal clouding etc.), aqueous humor protein rise etc., it has high safety, and can be an excellent agent for preventing and/or treating glaucoma etc.
Claims (1)
1. 2-Propanyl 4-{(3S,5aR,6R,7R,8aS)-6-[(1E,3R)-4-(2,5-difluorophenoxy)-3-hydroxy-1-buten-1-yl]-7-hydroxyoctahydro-2H-cyclopenta[b]oxepin-3-yl}butanoate.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jan 17, 2012
From: KAMBE, TOHRU; MARUYAMA, TORU; YAMANE, SHINSAKU; NAKAYAMA, SATOSHI; TANI, KOUSUKE
To: ONO PHARMACEUTICAL CO., LTD.
Reel/Frame 027540/0804 →
Priority Claims (1)
JP 2009-175246
· Jul 28, 2009
· national
Continuity (1)